Dasatinib, sold under the brand name Sprycel among others, is a targeted therapy medication used to treat certain cases of chronic myelogenous leukemia...
22 KB (1,994 words) - 04:41, 3 January 2024
except for T315I. Dasatinib is also not a substrate of multidrug P-glycoprotein efflux pumps like imatinib. Because of this dasatinib may be active in...
56 KB (6,475 words) - 07:21, 26 August 2024
to TK inhibitors, four novel agents were later developed. The first, dasatinib, blocks several further oncogenic proteins, in addition to more potent...
34 KB (3,877 words) - 01:25, 22 July 2024
sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib...
5 KB (232 words) - 10:23, 8 March 2024
are repurposed anti-cancer molecules, such as the chemotherapeutic drug dasatinib and the experimental small molecule navitoclax. Soluble urokinase plasminogen...
26 KB (2,028 words) - 10:24, 8 June 2024
are point-mutations in the kinase of BCR-abl. New inhibitors include dasatinib and nilotinib, which are significantly more potent than imatinib and may...
29 KB (3,538 words) - 15:01, 5 December 2023
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
121 KB (13,799 words) - 18:32, 22 August 2024
alefacept, and the tyrosine kinase inhibitors, imatinib, nilotinib, and dasatinib. Experimental therapies under investigation include endothelin receptor...
38 KB (3,293 words) - 18:29, 29 August 2024
D+Q may refer to: Dasatinib#Dasatinib+Quercetin Drawn & Quarterly This disambiguation page lists articles associated with the title D+Q. If an internal...
231 bytes (42 words) - 03:27, 19 December 2023
symptoms. Among currently available inhibitors to treat CML are imatinib, dasatinib, nilotinib, bosutinib and ponatinib. Gastrointestinal stromal tumors (GIST)...
43 KB (5,251 words) - 10:44, 24 June 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
31 KB (3,430 words) - 05:24, 28 August 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Prazitone Pyrimidinylpiperazine...
66 KB (6,680 words) - 22:22, 15 August 2024
kinases) have been developed for therapeutic use. One notable example is dasatinib which has been approved for the treatment of chronic myeloid leukemia...
21 KB (2,648 words) - 12:12, 26 July 2024
2006: FDA Approval of Dasatinib and Nilotinib for Resistant Leukemia MD Anderson researchers demonstrate the efficacy of dasatinib and nilotinib, leading...
54 KB (5,298 words) - 02:34, 23 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
68 KB (5,999 words) - 20:41, 31 August 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Prazitone Pyrimidinylpiperazine...
22 KB (1,721 words) - 05:27, 7 May 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
149 KB (15,717 words) - 06:34, 13 August 2024
nivolumab acts by inducing the immune system to attack the tumor. Sprycel (dasatinib) Taxol (paclitaxel). At one time, BMS held the solitary contract to harvest...
96 KB (7,620 words) - 00:01, 16 August 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Prazitone Pyrimidinylpiperazine...
83 KB (7,403 words) - 17:16, 15 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
13 KB (1,177 words) - 00:03, 12 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
92 KB (8,671 words) - 18:15, 17 August 2024
Additionally, tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib are incorporated for Philadelphia chromosome-positive ALL, improving treatment...
78 KB (7,754 words) - 23:38, 2 September 2024
replaced gefitinib in this setting. Sorafenib (Nexavar) Sunitinib (Sutent) Dasatinib (Sprycel) Lapatinib (Tykerb) Nilotinib (Tasigna) Bosutinib (Bosulif) Ponatinib...
20 KB (2,234 words) - 01:21, 22 July 2024
agents. PP1, PP2 (kinase inhibitor) are both inhibitors of Lck and FynT. Dasatinib Rivera-Torres J, José ES (2019). "Src Tyrosine Kinase Inhibitors: New...
3 KB (332 words) - 14:43, 20 November 2023
leukemia (CML) and later gefitinib and erlotinib aiming at the EGF receptor. Dasatinib is a Src tyrosine kinase inhibitor that is effective both as a senolytic...
10 KB (1,179 words) - 18:31, 8 August 2024
Agonists: Ancestim Stem cell factor Kinase inhibitors: Agerafenib Axitinib Dasatinib Imatinib Masitinib Nilotinib Pazopanib Quizartinib Sorafenib Sunitinib...
25 KB (2,086 words) - 02:24, 16 July 2024
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Prazitone Pyrimidinylpiperazine...
10 KB (814 words) - 04:38, 1 August 2024
Asparaginase Cladribine Clofarabine Cyclophosphamide Cytosine arabinoside Dasatinib Daunorubicin Decitabine Etoposide Fludarabine Gemtuzumab ozogamicin Idarubicin...
1 KB (70 words) - 18:51, 14 November 2023
Meclozine MT-45 Oxatomide SNC-80 Vanoxerine Pyrimidinylpiperazines Buspirone Dasatinib Eptapirone Gepirone Ipsapirone Piribedil Prazitone Pyrimidinylpiperazine...
4 KB (226 words) - 09:18, 22 August 2024
of exposure to drugs such as benfluorex (a fenfluramine derivative), dasatinib, cocaine, methamphetamine, ethanol leading to cirrhosis, and tobacco leading...
89 KB (8,902 words) - 09:54, 15 August 2024